...
首页> 外文期刊>Clinical kidney journal. >A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin
【24h】

A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin

机译:Gitelman综合征的严重表型,前列腺素排泄增加,对消炎痛的反应良好

获取原文
           

摘要

Our understanding of Gitelman syndrome (GS) and Bartter syndrome has continued to evolve with the use of genetic testing to more precisely define the tubular defects responsible. GS is caused by mutations in the SLC12A3 gene encoding the Na+–Cl? co-transporter of the distal convoluted tubule (NCCT) and tends to be associated with a milder salt-losing phenotype. We describe two female siblings presenting in infancy with a severe salt-losing tubulopathy and failure to thrive due to compound heterozygous mutations in the SLC12A3 gene encoding the NCCT. Both children were treated with indomethacin resulting in improved linear growth and polyuria. Some atypical biochemical findings in our cases are discussed including raised urinary prostaglandin (PGE2) excretion that normalized with intravenous fluid repletion.
机译:随着对基因检测的使用,我们对吉特曼综合症(GS)和巴特综合症的理解继续发展,以更精确地定义引起肾小管的缺陷。 GS是由远端螺旋小管(NCCT)的Na + –Cl ?共同转运蛋白编码的SLC12A3基因突变引起的,并倾向于与盐度较轻有关丧失表型。我们描述了在婴儿期出现严重失盐性肾小管病的两个女性兄弟姐妹,由于编码NCCT的SLC12A3基因中的复合杂合突变而无法壮成长。两名儿童均使用吲哚美辛治疗,导致线性生长和多尿症改善。讨论了我们病例中的一些非典型生化发现,包括尿液中前列腺素(PGE2)升高,并通过静脉补液正常化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号